Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVE: Depot methylprednisolone versus placebo in recent onset arthritis
2004-000803-17Phase 4Completed
- Sponsor
- SAVE Trial Group
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in undifferentiated arthritis (UA) comparing Depo-Medrol 120 mg with Placebo injection (2 arms). Primary endpoint: Clinical remission at 12 weeks and 1 year. Started Nov 2005; status: completed.
02
Drugs
methylprednisolone
03
Conditions
undifferentiated arthritis (UA)
Beyond the preview
Go deeper on 2004-000803-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000803-17.